Trial record 1 of 3 for:    cp18
Previous Study | Return to List | Next Study

Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

This study has been terminated.
(Unable to enroll breast cancer patients with current I/E criteria.)
Sponsor:
Information provided by (Responsible Party):
Siemens Molecular Imaging
ClinicalTrials.gov Identifier:
NCT01362712
First received: May 13, 2011
Last updated: May 17, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
No publications provided by Siemens Molecular Imaging

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):